NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Sees Significant Drop in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 1,200 shares, a decrease of 89.1% from the January 31st total of 11,000 shares. Based on an average trading volume of 23,700 shares, the days-to-cover ratio is presently 0.1 days.

NRx Pharmaceuticals Stock Performance

NRXPW stock opened at $0.10 on Friday. NRx Pharmaceuticals has a 1-year low of $0.04 and a 1-year high of $0.50. The company’s 50 day moving average is $0.19 and its 200 day moving average is $0.11.

About NRx Pharmaceuticals

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.